Dr. David Parkinson is the President and CEO of ESSA Pharma and is a member of the Board of Directors of a number of pharmaceutical startup companies. Prior to ESSA, Parkinson was a venture partner at New Enterprise Associates. Previously, Dr. Parkinson served as president and CEO of Nodality, and in senior management positions in oncology research and development at Biogen Idec, Amgen and Novartis. Dr. Parkinson has held academic positions at Tufts and the University of Texas MD Anderson Cancer Center, and is the author of over 100 peer-reviewed publications. Dr. David Parkinson received his medical degree from the University of Toronto.